Healthcare Licensing and Surveys logo

Healthcare Licensing and Surveys

Healthcare Licensing and Surveys (HLS) assures that residents and patients receive quality care from healthcare facilities required to be licensed by the State of Wyoming. HLS also promotes health and safety through on-site inspections and complaint investigations.

Contact Info:

2300 Capitol Avenue, Suite 510
Cheyenne, WY 82002
(307) 777-7123
Fax: (307) 777-7127
wdh-ohls@wyo.gov

S & C/QSO Memos 2022

  • QSO: 22-01-Hospice-Upcoming rulemaking for survey and enforcement requirements for hospice programs.
  • QSO: 22-02-ALL-Changes to COVID-19 Survey Activities and Increased Oversight in Nursing Homes.
  • QSO: 22-03-ASC & Hospitals-Ending the Streamlined Process for Ambulatory Surgical Centers and Independent Freestanding Emergency Departments to Temporarily Enroll as Hospitals during the COVID-19 Public Health Emergency
  • QSO: 22-04-ALL-Vaccination Regulation: Enforcement of Rule Imposing Vaccine Requirement for Health Care Staff in Medicare- and Medicaid-certified Providers and Suppliers is Suspended so Long as Court Ordered Injunctions Remain in Effect
  • QSO: 22-05-Hospitals (ADVISORY)-Evidence-based best practices for hospitals in managing obstetric emergencies and other key contributors to maternal health disparities
  • QSO: 22-06-AO/CLIA-FY 2020 Report to Congress (RTC): Review of Medicare’s Program Oversight of Accrediting Organizations (AOs) and the Clinical Laboratory Improvement Amendments of 1988 (CLIA) Validation Program
  • QSO: 22-07-ALL-Guidance for the Interim Final Rule – Medicare and Medicaid Programs; Omnibus COVID-19 Health Care Staff Vaccination
  • QSO: 22-08-NH-Nursing Home Staff Turnover and Weekend Staffing Levels
  • QSO: 22-09-ALL-Guidance for the Interim Final Rule – Medicare and Medicaid Programs; Omnibus COVID-19 Health Care Staff Vaccination – REVISED
  • QSO: 22-10-ALL-Vaccination Expectations for Surveyors Performing Federal Oversight
  • QSO: 22-11-ALL-(For Texas Only)-Guidance for the Interim Final Rule – Medicare and Medicaid Programs; Omnibus COVID-19 Health Care Staff Vaccination – REVISED
  • QSO: 22-12-ALL-State Obligations to Survey to the Entirety of Medicare and Medicaid Health and Safety Requirements under the 1864 Agreement
  • QSO: 22-13-CLIA-Clinical Laboratory Improvement Amendments (CLIA) Guidance for Temporary Testing Sites under the Multiple Site Exception
  • QSO: 22-14-CLIA-Clinical Laboratory Improvement Amendments of 1988 (CLIA) CMS Location and State Agency Updates to COVID-19 Survey Prioritization Guidance
  • QSO: 22-15-NH & NLTC & LSC-Update to COVID-19 Emergency Declaration Blanket Waivers for Specific Providers – REVISED
  • QSO: 22-16-ASC-Updated Guidance for Ambulatory Surgical Centers – Appendix L of the State Operations Manual (SOM)
  • QSO: 22-17-ALL-Surveys for compliance with Omnibus COVID-19 Health Care Staff Vaccination Requirements
  • QSO: 22-18-ALL-Rescission of the January 25, 2022 memo regarding Vaccination Expectations for Surveyors Performing Federal Oversight (QSO-22-10-ALL) and removal from its guidance repository
  • QSO: 22-19-NH-Revised Long-Term Care Surveyor Guidance: Revisions to Surveyor Guidance for Phases 2 & 3, Arbitration Agreement Requirements, Investigating Complaints & Facility Reported Incidents, and the Psychosocial Outcome Severity Guide
  • QSO: 22-20-Hospitals-Infection Prevention and Control and Antibiotic Stewardship Program Interpretive Guidance Update
  • QSO: 22-21-CLIA-Final Rule – Clinical Laboratory Improvement Amendments of 1988 (CLIA) Proficiency Testing – Analytes and Acceptable Performance Final Rule (CMS-3355-F)
  • QSO: 22-22-Hospitals-Reinforcement of EMTALA Obligations specific to Patients who are Pregnant or are Experiencing Pregnancy Loss (QSO-21-22-Hospitals-UPDATED JULY 2022)
  • QSO: 22-23-ALL-Preliminary injunction in Texas v. Becerra, No. 5:22-CV-185-H (N.D. Tex.)
  • QSO: 22-24-ESRD-FY2023 Dialysis Facility Outcomes List
  • QSO: 22-25-CLIA-CMS Rescinds December 7, 2020, Enforcement Discretion for the Use of SARS-CoV-2 Tests on Asymptomatic Individuals Outside of the Test’s Instructions for Use REVISED